共 50 条
- [21] Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1′ side chainJOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (10) : 2876 - 2885Majer, PavelHin, BundaStoermer, DorisAdams, JessicaXu, WeizhengDuvall, Bridget R.Delahanty, GregLiu, QunStathis, Marigo J.Wozniak, Krystyna M.Slusher, Barbara S.Tsukamoto, Takashi
- [22] Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moietiesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5584 - 5589Pinto, Donald J. P.Galemmo, Robert A., Jr.Quan, Mimi L.Orwat, Michael J.Clark, CharlesLi, RenhuaWells, BrianWoerner, FrancisAlexander, Richard S.Rossi, Karen A.Smallwood, AngelaWong, Pancras C.Luettgen, Joseph M.Rendina, Alan R.Knabb, Robert M.He, KanWexler, Ruth R.Lam, Patrick Y. S.
- [23] Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1788 - 1794Miller, JFAndrews, CWBrieger, MFurfine, ESHale, MRHanlon, MHHazen, RJKaldor, IMcLean, EWReynolds, DSarnmond, DMSpaltenstein, ATung, RTurner, EMXu, RXSherrill, RG
- [24] Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionPEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 672 - 673Feng, DMFreidinger, RMLevis, SDGardell, SJBock, MGChen, ZGNaylor-Olsen, AWoltmann, RBaskin, EPLynch, JJLucas, RShafer, JADancheck, KBChen, IWVacca, JP
- [25] Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groupsBIOORGANIC CHEMISTRY, 2024, 143Huang, QiaoQuan, BaoxueChen, YanZhao, XiuZhou, YanmeiHuang, ChongQiao, JingxinWang, YifeiLi, YueyueYang, ShengyongLei, JianLi, Linli
- [26] 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors.: Part 3:: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1229 - 1234Jia, ZZWu, YHHuang, WRZhang, PLSong, YHWoolfrey, JSinha, UArfsten, AEEdwards, STHutchaleelaha, AHollennbach, SJLambing, JLScarborough, RMZhu, BY
- [27] Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesJOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) : 461 - 473Burgey, CSRobinson, KALyle, TASanderson, PEJLewis, SDLucas, BJKrueger, JASingh, RMiller-Stein, CWhite, RBWong, BLyle, EAWilliams, PDCoburn, CADorsey, BDBarrow, JCStranieri, MTHolahan, MASitko, GRCook, JJMcMasters, DRMcDonough, CMSanders, WMWallace, AAClayton, FCBohn, DLeonard, YMDetwiler, TJLynch, JJYan, YWChen, ZGKuo, LGardell, SJShafer, JAVacca, JP
- [28] TACE inhibitors:: Discovery of 4-(2-methylouinolin-4-ylmethyl)phenyl as an effective P1′ group.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U957 - U957Chen, XTCorbett, RLGhavimi, BXue, CBWasserman, ZRLiu, RQCovington, MBQian, MXVaddi, KGChrist, DDHardman, KDRibadeneira, MDTrzaskos, JMNewton, RCDuan, JJWDecicco, CP
- [29] Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIaBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3006 - 3011Schweitzer, BANeumann, WLRahman, HKKusturin, CLSample, KRPoda, GIKurumbail, RGStevens, AMStegeman, RAStallings, WCSouth, MS
- [30] Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailabilityBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (19)Clark, Charles G.Rossi, Karen A.Corte, James R.Fang, TiananSmallheer, Joanne M.De Lucca, IndawatiNirschl, David S.Orwat, Michael J.Pinto, Donald J. P.Hu, ZilunWang, YufengYang, WuJeon, YoonEwing, William R.Myers, Joseph E., Jr.Sheriff, StevenLou, ZhenBozarth, Jeffrey M.Wu, YimingRendina, AlanHarper, TimothyZheng, JoannaXin, BaominXiang, QianLuettgen, Joseph M.Seiffert, Dietmar A.Wexler, Ruth R.Lam, Patrick Y. S.